2013 European guideline on the management of lymphogranuloma venereum

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 1, 2015, Pages 1-6

  De Vries, H J C ^a,b,c,d   Zingoni, A ^e   Kreuter, A ^f   Moi, H ^g   White, J A ^h  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Centre for Infectious Diseases and Immunology Amsterdam (CINIMA)   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY OF TURIN   (Italy)

^f St Elisabeth Hospital   (Germany)

^g UNIVERSITY OF OSLO   (Norway)

^h GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN;

CLINICAL FEATURE; DISEASE TRANSMISSION; EUROPEAN; HEALTH PROMOTION; HEPATITIS C VIRUS; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LYMPHOGRANULOMA VENEREUM; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; PROCTITIS; REINFECTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; FEMALE; MALE; MALE HOMOSEXUALITY; MICROBIOLOGY; PATIENT EDUCATION;

FEMALE; HOMOSEXUALITY, MALE; HUMANS; LYMPHOGRANULOMA VENEREUM; MALE; PATIENT EDUCATION AS TOPIC;

EID: 84919870854     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12461     Document Type: Review

References (32)

1. White JA,. Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis 2009; 22: 57-66.
2. Christerson L, de Vries HJ, de Barbeyrac B, et al,. Typing of lymphogranuloma venereum Chlamydia trachomatis strains. Emerg Infect Dis 2010; 16: 1777-1779.
3. Somboonna N, Wan R, Ojcius DM, et al,. Hypervirulent Chlamydia trachomatis clinical strain is a recombinant between lymphogranuloma venereum (L(2)) and D lineages. MBio 2011; 2: e00045-11.
4. Rönn MM, Ward H,. The association between lymphogranuloma venereum and HIV among men who have sex with men: systematic review and meta-analysis. BMC Infect Dis 2011; 11: 70.
5. Peuchant O, Baldit C, Le Roy C, et al,. First case of Chlamydia trachomatis L2b proctitis in a woman. Clin Microbiol Infect 2011; 17: E21-E23.
6. Verweij SP, Ouburg S, de Vries H, et al,. The first case record of a female patient with bubonic lymphogranuloma venereum (LGV), serovariant L2b. Sex Transm Infect 2012; 88: 346-347.
7. Vall-Mayans M, Caballero E, Sanz B,. The emergence of lymphogranuloma venereum in Europe. Lancet 2009; 374: 356.
8. Van der Ham R, De Vries HJ,. Lymphogranuloma venereum, where do we stand? Clinical recommendations. Drugs Today (Barc) 2009; 45 (Suppl. B): 39-43.
9. Ward H, Martin I, Macdonald N, et al,. Lymphogranuloma venereum in the United Kingdom. Clin Infect Dis 2007; 44: 26-32.
10. Spaargaren J, Fennema HS, Morré SA, de Vries HJ, Coutinho RA,. New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam. Emerg Infect Dis 2005; 11: 1090-1092.
11. van der Bij AK, Spaargaren J, Morre SA, et al,. Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: a retrospective case-control study. Clin Infect Dis 2006; 42: 186-194.
12. Martin IM, Alexander SA, Ison CA, Macdonald N, McCarthy K, Ward H,. Diagnosis of lymphogranuloma venereum from biopsy samples. Gut 2006; 55: 1522-1523.
13. Soni S, Srirajaskanthan R, Lucas SB, Alexander S, Wong T, White JA,. Lymphogranuloma venereum proctitis masquerading as inflammatory bowel disease in 12 homosexual men. Aliment Pharmacol Ther 2010; 32: 59-65.
14. Korhonen S, Hiltunen-Back E, Puolakkainen M,. Genotyping of Chlamydia trachomatis in rectal and pharyngeal specimens: identification of LGV genotypes in Finland. Sex Transm Infect 2012; 88: 465-469.
15. Pinsk I, Saloojee N, Friedlich M,. Lymphogranuloma venereum as a cause of rectal stricture. Can J Surg 2007; 50: E31-E32.
16. Halse TA, Musser KA, Limberger RJ,. A multiplexed real-time PCR assay for rapid detection of Chlamydia trachomatis and identification of serovar L-2, the major cause of lymphogranuloma venereum in New York. Mol Cell Probes 2006; 20: 290-297.
17. Hamill M, Benn P, Carder C, et al,. The clinical manifestations of anorectal infection with lymphogranuloma venereum (LGV) versus non-LGV strains of Chlamydia trachomatis: a case-control study in homosexual men. Int J STD AIDS 2007; 18: 472-475.
18. Jalal H, Stephen H, Alexander S, Carne C, Sonnex C,. Development of real-time PCR assays for genotyping of Chlamydia trachomatis. J Clin Microbiol 2007; 45: 2649-2653.
19. Morré SA, Spaargaren J, Fennema JS, de Vries HJ, Coutinho RA, Peña AS,. Real-time polymerase chain reaction to diagnose lymphogranuloma venereum. Emerg Infect Dis 2005; 11: 1311-1312.
20. Chen CY, Chi KH, Alexander S, Ison C, Ballard RC,. A real-time quadriplex PCR assay for the diagnosis of rectal lymphogranuloma venereum (LGV) and non-LGV Chlamydia trachomatis infections. Sex Transm Infect 2008; 84: 273-276.
21. de Vries HJ, Smelov V, Ouburg S, et al,. Anal lymphogranuloma venereum infection screening with IgA anti-Chlamydia trachomatis-specific major outer membrane protein serology. Sex Transm Dis 2010; 37: 789-795.
22. van der Snoek EM, Ossewaarde JM, van der Meijden WI, Mulder PG, Thio HB,. The use of serological titres of IgA and IgG in (early) discrimination between rectal infection with non-lymphogranuloma venereum and lymphogranuloma venereum serovars of Chlamydia trachomatis. Sex Transm Infect 2007; 83: 330-334.
23. Hill SC, Hodson L, Smith A,. An audit on the management of lymphogranuloma venereum in a sexual health clinic in London, UK. Int J STD AIDS 2010; 21: 772-776.
24. McLean CA, Stoner BP, Workowski KA,. Treatment of lymphogranuloma venereum. Clin Infect Dis 2007; 44 (Suppl. 3): S147-S152.
25. Centers for Disease Control and Prevention (CDC). Lymphogranuloma venereum among men who have sex with men-Netherlands, 2003-2004. MMWR Morb Mortal Wkly Rep 2004; 53: 985-988.
26. White J, O'Farrell N, Daniels D,. British Association for Sexual Health and HIV. UK National Guideline for the management of lymphogranuloma venereum: Clinical Effectiveness Group of the British Association for Sexual Health and HIV (CEG/BASHH) Guideline development group. Int J STD AIDS 2013; 24: 593-601.
27. Centers for Disease Control and Prevention (CDC);, Workowski KA, Berman SM,. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55: 1-94.
28. de Vries HJ, Smelov V, Middelburg JG, Pleijster J, Speksnijder AG, Morré SA,. Delayed microbial cure of lymphogranuloma venereum proctitis with doxycycline treatment. Clin Infect Dis 2009; 48: e53-e56.
29. Nieuwenhuis RF, Ossewaarde JM, van der Meijden WI, Neumann HA,. Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin. Sex Transm Infect 2003; 79: 453-455.
30. van Nieuwkoop C, Gooskens J, Smit VT, et al,. Lymphogranuloma venereum proctocolitis: mucosal T cell immunity of the rectum associated with chlamydial clearance and clinical recovery. Gut 2007; 56: 1476-1477.
31. Méchaï F, de Barbeyrac B, Aoun O, Mérens A, Imbert P, Rapp C,. Doxycycline failure in lymphogranuloma venereum. Sex Transm Infect 2010; 86: 278-279.
32. de Vries HJ, van der Bij AK, Fennema JS, et al,. Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior. Sex Transm Dis 2008; 35: 203-208.